Launch profitable NGS tests quickly with Fabric Genomics' streamlined interpretation platform and clinical services
| Growth in Testing | BRCA 1/2 | HBOC | CRC |
|---|---|---|---|
|
2016-2019 |
718% |
138% |
1400% |
CRC = colorectal cancer
HBOC = hereditary breast and ovarian cancer
*Xifin reimbursement data October 2020, excluding denials
Contracted and non-contracted
CMS published rates provided for reference
Getting started is simple
Our implementation team will help you finalize your test launch plan
We set up Fabric Enterprise for your lab including clinical workflows
Collect samples
and sequence
Fully automated interpretation
delivers reports in minutes
Our team of clinical experts assists in finalizing interpretation and drafting reports, as needed
• Comprehensive Fabric Enterprise installation
• Customized gene panels
• Configuration of clinical interpretation workflows (SOPs)
• Interpretation of panels, exomes, genomes at scale
• Clinical Services interpretation and sign out
• Lean on our network of ABMGG board-certified & board eligible medical genetics, and variant scientists
See how we can help you launch hereditary cancer testing
Learn how to get started and scale up today
Ready to
get started?
